| BAYER AG NA O.N. | 51.25 / -0.66% |
| Date/Time | 02/26 / 11:32 |
| Chg. / Chg.(%) | -0.34 / -0.66% |
| Bid | 51.25 / 220 |
| Ask | 51.27 / 238 |
| Open | 50.81 |
| Previous Close | 51.59 |
| High | 52.24 |
| Low | 50.60 |
| Volume [EUR] | 77,499,003.32 |
| Volume [Units] | 1,506,388 |
| Price fixings | 5555 |
| ISIN | DE000BAY0017 |
| Security | BAYN |
| Exchange | Xetra |
| Type | Stock |
| Bid Size | Bid | Ask | Ask size |
|---|---|---|---|
| 220 | 51.25 | 51.27 | 238 |
| 1,132 | 51.24 | 51.28 | 877 |
| 2,090 | 51.23 | 51.29 | 1,073 |
| 1,697 | 51.22 | 51.30 | 1,909 |
| 1,871 | 51.21 | 51.31 | 1,932 |
| 2,738 | 51.20 | 51.32 | 1,938 |
| 1,236 | 51.19 | 51.33 | 1,908 |
| 1,876 | 51.18 | 51.34 | 2,400 |
| 1,266 | 51.17 | 51.35 | 1,705 |
| 2,315 | 51.16 | 51.36 | 3,281 |
News
- Europe closes lower amid recovery uncertainties
02/25/2021 / 17:31 - TeleTrader - Daré Bioscience to Participate in Maxim Group’s Late Stage Innovations in Women’s Health Virtual Event
02/25/2021 / 14:00 - GlobeNewswire - Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
02/25/2021 / 13:00 - GlobeNewswire - Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
02/25/2021 / 12:45 - GlobeNewswire - Bayer posts Q4 revenue at €9.9 billion, down 7%
02/25/2021 / 10:10 - TeleTrader
Real-time